<DOC>
	<DOCNO>NCT00003944</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy plus peripheral stem cell transplantation treat patient stage III stage IV ovarian , fallopian tube , primary peritoneal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Treating Patients With Stage III Stage IV Ovarian , Fallopian Tube , Primary Peritoneal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine pathological complete response rate patient suboptimally debulked stage III stage IV ovarian , fallopian tube , primary peritoneal carcinoma treat sequential paclitaxel , carboplatin , topotecan peripheral blood stem cell rescue . II . Determine disease free overall survival patient . OUTLINE : Patients receive mobilization cyclophosphamide IV 1 hour , follow 4 hour later paclitaxel IV 24 hour . Filgrastim ( G-CSF ) administer subcutaneously begin 24 hour completion paclitaxel continue stem cell harvest . Peripheral blood stem cell ( PBSC ) harvest select CD34+ cell . High dose sequential chemotherapy begin 21 day leukapheresis . Patients receive paclitaxel IV 24 hour day 1 , carboplatin IV 2 hour day 2 , topotecan IV 24 hour . G-CSF administer subcutaneously begin day 3 blood count recover . PBSC reinfused day 4 . Treatment repeat every 28 day 4 course absence disease progression unacceptable toxicity . Patients radiographic biochemical complete response undergo second look surgery within 8 week complete last course chemotherapy . PROJECTED ACCRUAL : Approximately 28 patient accrue study .</detailed_description>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven ovarian , fallopian tube , primary peritoneal carcinoma Suboptimally debulked stage III ( great 1.0 cm residual disease ) Stage IV Histological subtypes allow include : Serous adenocarcinoma Mucinous adenocarcinoma Clear cell carcinoma Transitional cell carcinoma Endometrioid adenocarcinoma Undifferentiated adenocarcinoma Mixed epithelial adenocarcinoma Adenocarcinoma otherwise specify No borderline ovarian carcinoma low malignant potential histology Stage III disease patient must appropriate surgery ovarian , fallopian tube , primary peritoneal carcinoma retain suboptimally debulked disease ( great 1.0 cm residual disease ) No CNS involvement PATIENT CHARACTERISTICS : Age : 18 Performance status : GOG 0 1 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL AST ALT great 2 time upper limit normal Hepatitis negative Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Ureteral obstruction must successfully treat No renal failure Cardiovascular : No congestive heart failure No myocardial infarction within past 6 month No significant arrhythmia require medication No poorly control hypertension No poorly control systolic blood pressure No diastolic blood pressure consistently great 100 mmHg Pulmonary : No significant nonneoplastic pulmonary disease Other : No severe medical disease HIV negative No prior malignancy within past 5 year except squamous basal cell carcinoma skin , carcinoma situ cervix Second concurrent solid tumor malignancy allow life threaten require chemotherapy radiotherapy No acute infection No active peptic ulcer disease No uncontrolled diabetes mellitus No current psychiatric disease , alcohol abuse , drug abuse No prior hospitalization psychiatric disease include severe depression psychosis Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No hypersensitivity E. coli derive product PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy great 25 % bone marrow Surgery : See Disease Characteristics No great 8 week since debulking surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>ovarian undifferentiated adenocarcinoma</keyword>
	<keyword>ovarian mixed epithelial carcinoma</keyword>
	<keyword>ovarian serous cystadenocarcinoma</keyword>
	<keyword>ovarian mucinous cystadenocarcinoma</keyword>
	<keyword>ovarian endometrioid adenocarcinoma</keyword>
	<keyword>ovarian clear cell cystadenocarcinoma</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>peritoneal cavity cancer</keyword>
</DOC>